Literature DB >> 17988900

Does the intestinal bifidobacterial colonisation affect bacterial translocation?

Marie-Bénédicte Romond1, Michel Colavizza, Catherine Mullié, Nicolas Kalach, Odile Kremp, Christine Mielcarek, Daniel Izard.   

Abstract

The aim of this work was to investigate the possible role of the intestinal anaerobic flora (especially bifidobacteria) in regulating bacterial translocation (BT) which can be defined as the passage of intestinal microbes through the mucosa to internal organs. Default in BT regulation concurs with pathogenesis of sepsis in various human conditions, such as acute pancreatitis, cirrhosis, necrotising enterocolitis or multiple organ failure. The intestinal flora was studied in human flora associated mice (HF mice) and BT was quantified in Peyer's patches (PP), blood, spleen, liver and lungs. HF mice displayed a heterogenic intestinal colonisation with bifidobacteria. High colonisation of both caecum and colon by bifidobacteria led to a poorer bacterial contamination of blood, liver and lungs. Moreover, ileal, caecal and colonic bifidobacterial counts negatively correlated with the bacterial dissemination (number of contaminated organs per mouse). In contrast, Bacteroides fragilis group counts positively correlated with bacteraemia, lungs contamination or bacterial dissemination. Additionally, clostridia localised in the colon affected bacterial uptake by PP and lungs contamination as indicated by positive correlations between bacterial populations in these respective locations. These results indicate that bifidobacteria, when established in high counts, reduced BT to liver, blood and lungs, whereas B. fragilis group favoured the bacterial passage. Clostridia established in the distal ileum also seemed to favour BT to lungs. The manipulation of the bacterial flora to optimise the regulatory effect on BT should therefore focus on the selective promotion of bifidobacteria and avoid an increase in potentially detrimental populations such as B. fragilis group and clostridia.

Entities:  

Mesh:

Year:  2007        PMID: 17988900     DOI: 10.1016/j.anaerobe.2007.09.003

Source DB:  PubMed          Journal:  Anaerobe        ISSN: 1075-9964            Impact factor:   3.331


  15 in total

1.  Altered gut microbiome composition in patients with Vogt-Koyanagi-Harada disease.

Authors:  Zi Ye; Chunyan Wu; Ni Zhang; Liping Du; Qingfeng Cao; Xinyue Huang; Jihong Tang; Qingfeng Wang; Fuzhen Li; Chunjiang Zhou; Qian Xu; Xiao Xiong; Aize Kijlstra; Nan Qin; Peizeng Yang
Journal:  Gut Microbes       Date:  2020-01-13

Review 2.  Differential Establishment of Bifidobacteria in the Breastfed Infant Gut.

Authors:  Zachery T Lewis; David A Mills
Journal:  Nestle Nutr Inst Workshop Ser       Date:  2017-03-27

3.  Intestinal virome changes precede autoimmunity in type I diabetes-susceptible children.

Authors:  Guoyan Zhao; Tommi Vatanen; Lindsay Droit; Arnold Park; Aleksandar D Kostic; Tiffany W Poon; Hera Vlamakis; Heli Siljander; Taina Härkönen; Anu-Maaria Hämäläinen; Aleksandr Peet; Vallo Tillmann; Jorma Ilonen; David Wang; Mikael Knip; Ramnik J Xavier; Herbert W Virgin
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-10       Impact factor: 11.205

4.  A Bioluminescent Francisella tularensis SCHU S4 Strain Enables Noninvasive Tracking of Bacterial Dissemination and the Evaluation of Antibiotics in an Inhalational Mouse Model of Tularemia.

Authors:  Charlotte A Hall; Helen C Flick-Smith; Sarah V Harding; Helen S Atkins; Richard W Titball
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

Review 5.  Human intestinal microbiota and type 1 diabetes.

Authors:  Outi Vaarala
Journal:  Curr Diab Rep       Date:  2013-10       Impact factor: 4.810

Review 6.  Bifidobacterium longum subspecies infantis: champion colonizer of the infant gut.

Authors:  Mark A Underwood; J Bruce German; Carlito B Lebrilla; David A Mills
Journal:  Pediatr Res       Date:  2014-10-10       Impact factor: 3.756

Review 7.  Dysbiosis and Alzheimer's Disease: Cause or Treatment Opportunity?

Authors:  Manuel H Janeiro; María J Ramírez; Maite Solas
Journal:  Cell Mol Neurobiol       Date:  2021-01-05       Impact factor: 5.046

8.  Fecal microbiota composition differs between children with β-cell autoimmunity and those without.

Authors:  Marcus C de Goffau; Kristiina Luopajärvi; Mikael Knip; Jorma Ilonen; Terhi Ruohtula; Taina Härkönen; Laura Orivuori; Saara Hakala; Gjalt W Welling; Hermie J Harmsen; Outi Vaarala
Journal:  Diabetes       Date:  2012-12-28       Impact factor: 9.461

9.  Protective Actions of Oral Administration of Bifidobacterium longum CBi0703 in Spontaneous Osteoarthritis in Dunkin Hartley Guinea Pig Model.

Authors:  Yves Henrotin; Stéphane Patrier; Amandine Pralus; Mathilde Roche; Adrien Nivoliez
Journal:  Cartilage       Date:  2019-04-13       Impact factor: 3.117

10.  Validating bifidobacterial species and subspecies identity in commercial probiotic products.

Authors:  Zachery T Lewis; Guy Shani; Chad F Masarweh; Mina Popovic; Steve A Frese; David A Sela; Mark A Underwood; David A Mills
Journal:  Pediatr Res       Date:  2015-11-16       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.